Skip to main content
. 2011 Sep 26;17(Suppl 6):E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
Oral treatment Parenteral treatment
No risk of Pseudomonas spp. Amoxicillin‐clavulanateMoxifloxacinLevofloxacin
Risk of Pseudomonas spp.a Ciprofloxacinb Ceftazidime, or carbapenem, or piperacillin‐tazobactam

aUse the same criteria mentioned for chronic obstructive pulmonary disease exacerbation.

bLevofloxacin 750 mg/24 h or 500 mg twice daily is an alternative.